Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antigen-Specific Stimulation and Expansion of CAR-T Cells Using Membrane Vesicles as Target Cell Surrogates.
Ukrainskaya V, Rubtsov Y, Pershin D, Podoplelova N, Terekhov S, Yaroshevich I, Sokolova A, Bagrov D, Kulakovskaya E, Shipunova V, Deyev S, Ziganshin R, Chernov A, Telegin G, Maksimov E, Markov O, Oshchepkova A, Zenkova M, Xie J, Zhang H, Gabibov A, Maschan M, Stepanov A, Lerner R. Ukrainskaya V, et al. Among authors: maschan m. Small. 2021 Nov;17(45):e2102643. doi: 10.1002/smll.202102643. Epub 2021 Oct 3. Small. 2021. PMID: 34605165
Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.
Klimentova M, Shelikhova L, Ilushina M, Kozlovskaya S, Blagov S, Popov A, Kashpor S, Fadeeva M, Olshanskaya J, Glushkova S, Pershin D, Balashov D, Maschan A, Maschan M. Klimentova M, et al. Among authors: maschan m, maschan a. Transplant Cell Ther. 2023 Feb;29(2):127.e1-127.e9. doi: 10.1016/j.jtct.2022.11.022. Epub 2022 Nov 25. Transplant Cell Ther. 2023. PMID: 36436779 Free article. Clinical Trial.
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
Glushkova S, Shelikhova L, Voronin K, Pershin D, Vedmedskaya V, Muzalevskii Y, Kazachenok A, Kurnikova E, Radygina S, Ilushina M, Khismatullina R, Maschan A, Maschan M. Glushkova S, et al. Among authors: maschan m. Transplant Cell Ther. 2024 Apr;30(4):435.e1-435.e12. doi: 10.1016/j.jtct.2024.01.070. Epub 2024 Jan 24. Transplant Cell Ther. 2024. PMID: 38278183
Control of graft-versus-host disease with rabbit anti-thymocyte globulin, rituximab, and bortezomib in TCRαβ/CD19-depleted graft transplantation for leukemia in children: a single-center retrospective analysis of two GVHD-prophylaxis regimens.
Shekhovtsova Z, Shelikhova L, Balashov D, Zakharova V, Ilushina M, Voronin K, Kurnikova E, Muzalevskii Y, Kazachenok A, Pershin D, Novichkova G, Maschan A, Maschan M. Shekhovtsova Z, et al. Among authors: maschan m, maschan a. Pediatr Transplant. 2020 Feb;24(1):e13594. doi: 10.1111/petr.13594. Epub 2019 Nov 3. Pediatr Transplant. 2020. PMID: 31680369
Plerixafor added to G-CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR-alpha/beta depletion in pediatric haploidentical and genoidentical donors failing to mobilize with G-CSF alone.
Kurnikova E, Trakhtman P, Pershin D, Ilyushina M, Khismatullina R, Maschan M, Novichkova G, Maschan A. Kurnikova E, et al. Among authors: maschan m, maschan a. J Clin Apher. 2021 Aug;36(4):547-552. doi: 10.1002/jca.21891. Epub 2021 Mar 8. J Clin Apher. 2021. PMID: 33682959
Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival.
Kalinin RS, Ukrainskaya VM, Chumakov SP, Moysenovich AM, Tereshchuk VM, Volkov DV, Pershin DS, Maksimov EG, Zhang H, Maschan MA, Rubtsov YP, Stepanov AV. Kalinin RS, et al. Among authors: maschan ma. Front Mol Biosci. 2021 Oct 13;8:745286. doi: 10.3389/fmolb.2021.745286. eCollection 2021. Front Mol Biosci. 2021. PMID: 34722633 Free PMC article.
97 results